Camber Pharma Launches Generic Sabril®
Piscataway, NJ, April 20, 2021– Camber Pharmaceuticals is pleased to announce that it has launched Vigabatrin for Oral Solution, which is the generic version of Sabril®
Vigabatrin for Oral Solution is used in combination with other medications to treat seizure disorders.
Vigabatrin for Oral Solution is available from Camber in 500mg- 50 packet cartons.
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected].
Recent articles
- NACDS TSE 2026 Event Recap
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio






